- Home
- TTC vs PCVX Comparison
TTC vs PCVX Comparison
Compare TTC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTC
- PCVX
- Stock Information
- Founded
- TTC 1914
- PCVX 2013
- Country
- TTC United States
- PCVX United States
- Employees
- TTC N/A
- PCVX N/A
- Industry
- TTC Tools/Hardware
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TTC Consumer Discretionary
- PCVX Health Care
- Exchange
- TTC Nasdaq
- PCVX Nasdaq
- Market Cap
- TTC 7.0B
- PCVX 4.4B
- IPO Year
- TTC N/A
- PCVX 2020
- Fundamental
- Price
- TTC $75.10
- PCVX $35.76
- Analyst Decision
- TTC Hold
- PCVX Strong Buy
- Analyst Count
- TTC 4
- PCVX 10
- Target Price
- TTC $82.00
- PCVX $136.50
- AVG Volume (30 Days)
- TTC 940.8K
- PCVX 1.5M
- Earning Date
- TTC 09-04-2025
- PCVX 08-05-2025
- Dividend Yield
- TTC 2.02%
- PCVX N/A
- EPS Growth
- TTC 54.24
- PCVX N/A
- EPS
- TTC 3.89
- PCVX N/A
- Revenue
- TTC $4,545,800,000.00
- PCVX N/A
- Revenue This Year
- TTC N/A
- PCVX N/A
- Revenue Next Year
- TTC $3.15
- PCVX N/A
- P/E Ratio
- TTC $19.35
- PCVX N/A
- Revenue Growth
- TTC 2.94
- PCVX N/A
- 52 Week Low
- TTC $62.34
- PCVX $27.66
- 52 Week High
- TTC $100.93
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- TTC 59.27
- PCVX 57.77
- Support Level
- TTC $73.15
- PCVX $31.79
- Resistance Level
- TTC $77.14
- PCVX $36.89
- Average True Range (ATR)
- TTC 1.69
- PCVX 1.51
- MACD
- TTC 0.56
- PCVX 0.37
- Stochastic Oscillator
- TTC 76.44
- PCVX 77.65
About TTC Toro Company (The)
The Toro Co manufactures turf maintenance and landscaping equipment. The company produces reel and rotary riding products, trim cutting and walking mowers, greens rollers, turf sprayer equipment, underground irrigation systems, heavy-duty walk-behind mowers, and sprinkler systems used for professional turf and landscape maintenance and construction. Its products are marketed through a network of distributors and dealers to predominantly professional users maintaining turfs and sports fields such as golf courses. Its operating segments are Professional which generates a substantial part of its revenue, and Residential segment. The company also produces snow plowers and ice management products. Its key revenue generating market is the United States.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.